methylprednisolone hemisuccinate has been researched along with T-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, WZ; Zhang, QY; Zhao, S | 1 |
| Avnir, Y; Barenholz, Y; Gabizon, A; Kizelsztein, P; Sigal, A; Tulchinsky, D; Turjeman, K; Tzemach, D | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and T-Cell Lymphoma
| Article | Year |
|---|---|
[Gemcitabine combined with cisplatin and methylprednisolone sodium succinate in chemotherapy for relapsed or refractory T cell non-Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 2010 |
Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids.
Topics: Animals; Capsules; Chemical Phenomena; Chemistry, Pharmaceutical; Encephalomyelitis, Autoimmune, Experimental; Female; Glucocorticoids; Humans; Hydrophobic and Hydrophilic Interactions; Leukemia; Liposomes; Lymphoma, T-Cell; Methylprednisolone Hemisuccinate; Mice; Multiple Sclerosis; Myelin Proteolipid Protein; Nanostructures; Solubility; Water | 2011 |